Filter Results:
(333)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
- 23 Jan 2019
- News
The Promise of Personalized Medicine
and a 501(c)(3) called Cure Rare Disease. With the foundation, Horgan is trying to build something radical: A model for personalizing drug development, with the hopes of saving not only his brother but countless others. READ MORE Morrell:... View Details
- 01 Mar 2009
- News
Model Patient
care, plus some drug coverage — was rejected. It smacked of a “two-tiered” system, he says, and was unacceptable for political reasons. Costs have thus been significantly higher than expected because the standard plan — with a relatively... View Details
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by... View Details
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 31 May 2018
- News
Finding Freedom from Eating Disorders
industry. Because so many people are not getting the treatment they deserve. Flint: You've developed a coaching practice called OutshiningED. What were some of the areas you wanted to address with that? Ronga: I dove in on this research... View Details
- 08 Jun 2010
- First Look
First Look: June 8
had to be updated to enable collaboration. The current dilemma facing the CEO and COO of the foundation relates to setting strategic priorities for research so that a treatment for MS can be ready in the next ten years. The strategic... View Details
Keywords: Martha Lagace
- 30 Mar 2010
- First Look
First Look: March 30
regulatory objections were debated and tensions rose between U.S. and EC regulators. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/310086-PDF-ENG Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
their dividend policy to serve their institutional shareholders. Download the paper: http://papers.nber.org/papers/W13283 Taxes and Portfolio Choice: Evidence from JGTRRA's Treatment of International Dividends Authors:Mihir A. Desai and... View Details
Keywords: Martha Lagace
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 01 Mar 2006
- News
One-on-One with Dr. Margaret Chan
treatments of the antiviral drug Tamiflu we have ready to dispatch on an emergency basis to contain a pandemic may not be deployed in time. In the case of H5N1, is enough being done to destroy infected... View Details
- 27 Sep 2011
- First Look
First Look: September 27
(forthcoming) An abstract is unavailable at this time. The Variance of Non-Parametric Treatment Effect Estimators in the Presence of Clustering Authors:Samuel G. Hanson and Adi Sunderam Publication:The Review of Economics and Statistics... View Details
Keywords: Sean Silverthorne
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
potential for multiple breakthroughs related to the specific tumor segmentation task of radiation oncologists while also addressing technological issues (e.g., reframing and conducting sequential competition phases). Lagace: What made this problem in cancer View Details
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed... View Details
Keywords: by Carmen Nobel & Anna Secino
- 01 Mar 2013
- News
Opening the Door
neighborhood-based health plan for the city of Charlestown, and I became involved in building a system of benchmarks for the various services that were being offered—everything from dental care to drug and alcohol abuse counseling. I... View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- Web
Winners & Success Stories | New Venture Competition
Business Track, 2024 New Venture Competition video Play Video duration: 1:35 2024 New Venture Competition Runner-Up, Business Track: Sanso Sanso is helping drug manufacturers produce life-saving biologics more efficiently, in order to... View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
the pandemic. Most have not been very successful. An examination of three strategies for distributing antiretroviral drugs (ARVs) to patients in three countries on three continents, Africa, Asia, and South America, suggests a customer... View Details
Keywords: Sean Silverthorne
- 04 Aug 2009
- First Look
First Look: August 4
709-474 In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health care in two rural districts in Eastern Rwanda and create an HIV treatment program at... View Details
Keywords: Martha Lagace
- 01 Dec 2013
- News
Curing Health Care
Massachusetts Governor Deval Patrick joked in his speech.) Related Links A Blueprint for Patient-Driven Drug Development Gene Williams (MBA 1987) Blavatnik Gift Accelerates Biomedical Advances Oscar Winners Even worse is what... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
a computer model of a potential mRNA-based vaccine. Twenty-five days after that, it produced the first dose of a treatment it hoped would protect against a disease that did not yet have a name. On February 24, after 17 days of analysis... View Details